Supplementary Data for "Myricone C neutralizes gastrointestinal malignancies through concurrent PERK-eIF2α-ATF4-CHOP activation and ROCK1/2 inhibition"
Published: 30 July 2026| Version 1 | DOI: 10.17632/ngrcdsh28h.1
Contributors:
Myungsuk Kim, Description
This dataset contains comprehensive statistical modeling parameters (One-way/Two-way ANOVA and Linear Mixed-Effects Models) and multi-omics (RNA-seq and exploratory proteomics) pathway enrichment results supporting the research article titled "Myricone C neutralizes gastrointestinal malignancies through concurrent PERK-eIF2α-ATF4-CHOP activation and ROCK1/2 inhibition".
Files
Institutions
- Korea Institute of Science and TechnologySeoul, Seoul
Categories
Pharmacology, Cancer Research